Your browser doesn't support javascript.
loading
Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization.
Ming-Chin Lee, Kevin; Achuthan, Adrian A; De Souza, David P; Lupancu, Tanya J; Binger, Katrina J; Lee, Man K S; Xu, Yangsong; McConville, Malcolm J; de Weerd, Nicole A; Dragoljevic, Dragana; Hertzog, Paul J; Murphy, Andrew J; Hamilton, John A; Fleetwood, Andrew J.
Afiliación
  • Ming-Chin Lee K; The Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
  • Achuthan AA; The Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
  • De Souza DP; Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3052 Australia.
  • Lupancu TJ; The Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
  • Binger KJ; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086, Australia.
  • Lee MKS; Haematopoiesis and Leukocyte Biology, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
  • Xu Y; Haematopoiesis and Leukocyte Biology, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
  • McConville MJ; The Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia; Department of Biochemistry and Molecular Biology, Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, Parkville, VIC 3050, Australia.
  • de Weerd NA; Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
  • Dragoljevic D; Haematopoiesis and Leukocyte Biology, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
  • Hertzog PJ; Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
  • Murphy AJ; Haematopoiesis and Leukocyte Biology, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
  • Hamilton JA; The Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, VIC 3021, Australia.
  • Fleetwood AJ; The Department of Medicine, University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia; Haematopoiesis and Leukocyte Biology, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 3004, Australia. Electronic address: andrew.fleetwood@baker.edu.au.
Cell Rep ; 39(3): 110719, 2022 04 19.
Article en En | MEDLINE | ID: mdl-35443173
ABSTRACT
Metabolic adaptations can directly influence the scope and scale of macrophage activation and polarization. Here we explore the impact of type I interferon (IFNß) on macrophage metabolism and its broader impact on cytokine signaling pathways. We find that IFNß simultaneously increased the expression of immune-responsive gene 1 and itaconate production while inhibiting isocitrate dehydrogenase activity and restricting α-ketoglutarate accumulation. IFNß also increased the flux of glutamine-derived carbon into the tricarboxylic acid cycle to boost succinate levels. Combined, we identify that IFNß controls the cellular α-ketoglutarate/succinate ratio. We show that by lowering the α-ketoglutarate/succinate ratio, IFNß potently blocks the JMJD3-IRF4-dependent pathway in GM-CSF and IL-4 activated macrophages. The suppressive effects of IFNß on JMJD3-IRF4-dependent responses, including M2 polarization and GM-CSF-induced inflammatory pain, were reversed by supplementation with α-ketoglutarate. These results reveal that IFNß modulates macrophage activation and polarization through control of the cellular α-ketoglutarate/succinate ratio.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Activación de Macrófagos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón Tipo I / Activación de Macrófagos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Australia